Annual SGA
$38.47 M
+$6.17 M+19.12%
December 1, 2024
Summary
- As of March 10, 2025, TRDA annual SGA is $38.47 million, with the most recent change of +$6.17 million (+19.12%) on December 1, 2024.
- During the last 3 years, TRDA annual SGA has risen by +$23.26 million (+153.04%).
- TRDA annual SGA is now at all-time high.
Performance
TRDA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$9.86 M
-$112.00 K-1.12%
December 1, 2024
Summary
- As of March 10, 2025, TRDA quarterly SGA is $9.86 million, with the most recent change of -$112.00 thousand (-1.12%) on December 1, 2024.
- Over the past year, TRDA quarterly SGA has stayed the same.
- TRDA quarterly SGA is now -1.12% below its all-time high of $9.97 million, reached on September 30, 2024.
Performance
TRDA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$547.74 M
+$65.63 M+10.70%
December 1, 2024
Summary
- As of March 10, 2025, TRDA TTM SGA is -$547.74 million, with the most recent change of +$65.63 million (+10.70%) on December 1, 2024.
- Over the past year, TRDA TTM SGA has dropped by -$586.20 million (-1523.99%).
- TRDA TTM SGA is now -1188.46% below its all-time high of -$42.51 million.
Performance
TRDA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TRDA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.1% | 0.0% | -1524.0% |
| 3 y3 years | +153.0% | -0.3% | -1887.7% |
| 5 y5 years | +966.1% | -0.3% | -1887.7% |
TRDA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +153.0% | -1.1% | +61.7% | -138.5% | +31.2% |
| 5 y | 5-year | at high | +966.1% | -1.1% | +674.5% | -1188.5% | +31.2% |
| alltime | all time | at high | +966.1% | -1.1% | +674.5% | -1188.5% | +31.2% |
Entrada Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $38.47 M(+19.1%) | $9.86 M(-1.1%) | $38.47 M(+3.2%) |
| Sep 2024 | - | $9.97 M(+8.0%) | $37.26 M(+7.0%) |
| Jun 2024 | - | $9.24 M(-1.7%) | $34.82 M(+3.2%) |
| Mar 2024 | - | $9.40 M(+8.6%) | $33.75 M(+4.5%) |
| Dec 2023 | $32.29 M(+5.4%) | $8.65 M(+14.9%) | $32.29 M(-3.7%) |
| Sep 2023 | - | $7.53 M(-7.8%) | $33.53 M(+1.7%) |
| Jun 2023 | - | $8.17 M(+2.9%) | $32.98 M(+2.6%) |
| Mar 2023 | - | $7.94 M(-19.8%) | $32.14 M(+4.9%) |
| Dec 2022 | $30.64 M | $9.89 M(+41.8%) | $30.64 M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $6.98 M(-4.9%) | $26.84 M(+13.2%) |
| Jun 2022 | - | $7.33 M(+14.0%) | $23.72 M(+21.9%) |
| Mar 2022 | - | $6.43 M(+5.5%) | $19.46 M(+28.0%) |
| Dec 2021 | $15.20 M(+173.2%) | $6.10 M(+58.3%) | $15.20 M(+36.9%) |
| Sep 2021 | - | $3.85 M(+25.0%) | $11.10 M(+30.3%) |
| Jun 2021 | - | $3.08 M(+42.0%) | $8.52 M(+56.6%) |
| Mar 2021 | - | $2.17 M(+8.7%) | $5.44 M(+66.4%) |
| Dec 2020 | $5.57 M(+54.2%) | $2.00 M(+56.9%) | $3.27 M(+156.9%) |
| Sep 2020 | - | $1.27 M | $1.27 M |
| Dec 2019 | $3.61 M | - | - |
FAQ
- What is Entrada Therapeutics annual SGA?
- What is the all time high annual SGA for Entrada Therapeutics?
- What is Entrada Therapeutics annual SGA year-on-year change?
- What is Entrada Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly SGA year-on-year change?
- What is Entrada Therapeutics TTM SGA?
- What is the all time high TTM SGA for Entrada Therapeutics?
- What is Entrada Therapeutics TTM SGA year-on-year change?
What is Entrada Therapeutics annual SGA?
The current annual SGA of TRDA is $38.47 M
What is the all time high annual SGA for Entrada Therapeutics?
Entrada Therapeutics all-time high annual SGA is $38.47 M
What is Entrada Therapeutics annual SGA year-on-year change?
Over the past year, TRDA annual SGA has changed by +$6.17 M (+19.12%)
What is Entrada Therapeutics quarterly SGA?
The current quarterly SGA of TRDA is $9.86 M
What is the all time high quarterly SGA for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly SGA is $9.97 M
What is Entrada Therapeutics quarterly SGA year-on-year change?
Over the past year, TRDA quarterly SGA has changed by $0.00 (0.00%)
What is Entrada Therapeutics TTM SGA?
The current TTM SGA of TRDA is -$547.74 M
What is the all time high TTM SGA for Entrada Therapeutics?
Entrada Therapeutics all-time high TTM SGA is -$42.51 M
What is Entrada Therapeutics TTM SGA year-on-year change?
Over the past year, TRDA TTM SGA has changed by -$586.20 M (-1523.99%)